Detalles de la búsqueda
1.
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Cancer Immunol Immunother;
69(8): 1549-1564, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303794
2.
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.
Breast Cancer Res;
20(1): 15, 2018 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29482642
3.
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
J Transl Med;
15(1): 30, 2017 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193231
4.
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
J Neurooncol;
134(2): 443-451, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28687923
5.
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
J Transl Med;
14(1): 136, 2016 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184134
6.
The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.
BMC Neurol;
16(1): 190, 2016 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27716097
7.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
J Transl Med;
13: 171, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021752
8.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC Cancer;
13: 163, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537287
9.
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Breast Cancer Res;
14(6): R145, 2012 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23146280
10.
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.
J Transl Med;
10: 212, 2012 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23092535
11.
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
J Transl Med;
10: 10, 2012 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240029
12.
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
BMC Cancer;
12: 271, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748098
13.
Prognostic utility of ß-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Breast Cancer Res Treat;
127(1): 179-93, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21390496
14.
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
Lancet Oncol;
11(8): 753-62, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20619739
15.
The Role of CXCL13 and CXCL9 in Early Breast Cancer.
Clin Breast Cancer;
20(1): e36-e53, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31699671
16.
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast Cancer Res Treat;
116(1): 131-43, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18668363
17.
Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.
Anticancer Res;
29(2): 529-38, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19331199
18.
Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry.
Clin Cancer Res;
25(10): 3054-3062, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796036
19.
Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab.
Transl Oncol;
12(5): 739-748, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30877976
20.
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.
Cancer Invest;
26(8): 784-93, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18798073